Cost-Utility Analysis of Infliximab with Standard Care versus Standard Care Alone for Induction and Maintenance Treatment of Patients with Ulcerative Colitis in Poland.
about
Cost-effectiveness of biological treatment of ulcerative colitis - a systematic review.A systematic review of cost-effectiveness studies comparing conventional, biological and surgical interventions for inflammatory bowel disease.A Systematic Review of the Cost-Effectiveness of Biologics for Ulcerative Colitis.Economic Evaluations of Treatments for Inflammatory Bowel Diseases: A Literature Review.
P2860
Cost-Utility Analysis of Infliximab with Standard Care versus Standard Care Alone for Induction and Maintenance Treatment of Patients with Ulcerative Colitis in Poland.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Cost-Utility Analysis of Infli ...... Ulcerative Colitis in Poland.
@en
Cost-Utility Analysis of Infli ...... Ulcerative Colitis in Poland.
@nl
type
label
Cost-Utility Analysis of Infli ...... Ulcerative Colitis in Poland.
@en
Cost-Utility Analysis of Infli ...... Ulcerative Colitis in Poland.
@nl
prefLabel
Cost-Utility Analysis of Infli ...... Ulcerative Colitis in Poland.
@en
Cost-Utility Analysis of Infli ...... Ulcerative Colitis in Poland.
@nl
P2860
P356
P1433
P1476
Cost-Utility Analysis of Infli ...... Ulcerative Colitis in Poland.
@en
P2093
Ewa Stawowczyk
Paweł Kawalec
P2860
P304
P356
10.1002/PHAR.1742
P407
P50
P577
2016-03-23T00:00:00Z